×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

TYBOURNE CAPITAL MANAGEMENT (HK) LTD

13-F Portfolio Value: $30.93 M
Last 13-F Filed: Q3 2025
Concentration in top 10: 100%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
TSHATAYSHA GENE THERAPIES INC (TSHA US)39.11%3,700,000$12,099,000-395,000-9.65%$3.2713F
FBRXFORTE BIOSCIENCES INC (FBRX US)38.15%786,647$11,799,705No Change$1513F
ALMSALUMIS INC (ALMS US)18.05%1,399,250$5,583,008No Change$3.9913F
ZNTLZENTALIS PHARMACEUTICALS INC (ZNTL US)4.69%961,486$1,451,844-516,666-34.95%$1.5113F
BCYCBICYCLE THERAPEUTICS LTD-ADR (BCYC US)-993,743Exited13F
MBUUMALIBU BOATS INC (MBUU US)-66,705Exited13F